for Jan 27, 2023
🔥NEW🔥 @PharmacoJournal@LinaMengPharmD @DHpharmd@EmilyMui @StanDeresinski @StanfordASP
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
Comprehensive Guidance for Antibiotic Dosing in Obese Adults: 2022 Update #IDTwitter
cc @SIDPharm @accpinfdprn @IDstewardship @InfectiousDz @DosingMatters #paywall☹️https://t.co/otqUjYoMn5
Congratulations @IDdocChen @HHoangMD @carliocer et al: RCT of antimicrobial stewardship intervention in patients hospitalised w/COVID-19 in @TheLancetInfDis @UofA_ID @UAlberta_DoM @UAlberta_FoMD https://t.co/D7b9cGRzx4
— UofA Infectious Diseases (@UofA_ID) January 27, 2023
🙌 “Implementing a real-time EHR antimicrobial report run by pharmacists in the ED was associated with significantly fewer major delays in subsequent antibiotic dosing following a first dose.” via @AJHPOfficial https://t.co/rFAVmaBrGI #EMtwitter #TwitteRx @accpemedprn pic.twitter.com/iQD6TABmUX
— ACCP INFD PRN (@accpinfdprn) January 27, 2023
Uncomplicated Streptococcal Bacteremia: The Era of Stepdown to Oral Antibiotic Therapy? https://t.co/mExF1xLSZw pic.twitter.com/CF3vM9X2y2
— Tristan Timbrook (@TristanTimbrook) January 27, 2023
📄 New article in @AJHPOfficial: “…resulted in increased use of β-lactam antibiotics, decreased use of second-line antibiotics, and decreased costs without a significant change in the incidence of adverse reactions.”https://t.co/Ca5A8WjMe6 #TwitteRx #MedTwitter pic.twitter.com/bdOHMRFuYJ
— SIDP (@SIDPharm) January 27, 2023
Congratulations to Dr. Carlos Del Rio for becoming the Interim Emory SOM Dean and Chief Academic officer for Emory Healthcare on March 1st!
— Woodruff Health Sciences Center Library (@EmoryHealthLibr) January 27, 2023
image: https://t.co/d472wItyro
@@CarlosdelRio7 @emoryhealthcare @emoryhealthsci @EmoryMedicine @EmoryNursing @EmoryRollins @EmoryUniversity pic.twitter.com/MY5BBG1RVC
The final first author paper of my #PhD at @EmoryMMG is now online at #MicrobiologySpectrum! @ASMicrobiology @JournalSpectrum @rpetit3 #bacteriology #visa #staphylococcusaureus #infectiousdiseases #nanopore #amplicon https://t.co/dZ5KAfAiqW
— Abraham Moller, PhD (@abraham_moller) January 27, 2023
Japan has decided to downgrade COVID-19 to the same category of infectious diseases as seasonal influenza on May 8.https://t.co/UrfVfHCqFT
— NHK WORLD News (@NHKWORLD_News) January 27, 2023
📄 New in @ICHEJournal — “…SSTOP may serve to achieve sustainable promotion of antibiotic use improvements.”
— ACCP INFD PRN (@accpinfdprn) January 27, 2023
Great work from @VAStewie folks on a project years in the making. Congrats! 👏👏👏
📲 https://t.co/hqbVwRFke6 #IDtwitter #ASPtwitter #SaveABX pic.twitter.com/qFRttZ6ASk
For anyone who finds this topic particularly interesting, I want to remind everyone that CIDRAP has a podcast called “Superbugs and You” that covers #antimicrobialresistance, with stories from patients, physicians, and researchers from around the world. https://t.co/gvbCLd2anA
— Michael Osterholm (@mtosterholm) January 27, 2023
🆕️⚡️⚡️ @OFIDJournal@mcastanheirajmi
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
Trends of β-Lactamase Occurrence among Escherichia coli and Klebsiella pneumoniae in United States Hospitals during a 5-year period and Activity of Antimicrobial Agents against Isolates Stratified by β-Lactamase Type1 https://t.co/0TEssZxoLo
Devon #care #homes say they are being asked to accept patients with #Covid-19, flu and other infectious diseases to ease the pressure on local hospitals.🫤https://t.co/vpQpB1sW1s
— Amanda Tomlins😷🐾🇪🇺🏳️🌈Still Shielding (@tomlins_amanda) January 27, 2023
An important study on antimicrobial stewardship in hospitals https://t.co/vVIai19jXO that should be rolled out. Robust implementation and senior clinical leadership critical though @DrKieranHand @UKAMREnvoy @NHSEnglandNMD
— Keith Ridge (@keithridge1) January 27, 2023
Episode 8: “The Clap claps back—resistant gonorrhea” includes interviews of clinicians and drug developers discussing concerns and promising research related to antibiotic resistant gonorrhea. https://t.co/4M4wUYa3QN
— Michael Osterholm (@mtosterholm) January 27, 2023
7 MONTHS PROTECTION ?@MeetJess @RadCentrism@FLAHAULT @RolandBakerIII
— Emmanuel Justin (@ejustin46) January 27, 2023
"7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection" - The Lancet Infectious Diseaseshttps://t.co/ft6enq0FDc pic.twitter.com/bYvezPuGZe
An expert panel of Japan's health ministry agreed on Friday that COVID-19 should be downgraded to the same category of infectious diseases as seasonal influenza in about three months.https://t.co/mbVYCexoWD
— NHK WORLD News (@NHKWORLD_News) January 27, 2023
“Devon care homes say they are being asked to accept patients with Covid-19, flu and other infectious diseases to ease the pressure on local hospitals.”https://t.co/yjD9Ug6L1i
— Covid Solidarity (@CovidSolidarit1) January 27, 2023
Seen creative ways to raise awareness & engagement on bacteria and resistance? Here is one from @react_latina!
— ReAct - Action on Antibiotic Resistance (@reactgroup) January 27, 2023
Dancing with bacteria: a theatrical performance about #AntibioticResistance (do yo see the #bacteria in the backdrop? 🙂)More in ReAct article 👇🏾https://t.co/JLCKJahTxP pic.twitter.com/HVclJYGSOy
#AI has designed anti-microbial proteins that were then tested in the lab & shown to work.
— MicrobesInfect (@MicrobesInfect) January 27, 2023
The researchers selected 5 candidate proteins with & added them to a sample of Escherichia coli. Two of the proteins destroyed the bacteriahttps://t.co/7w8C1unWlt #ArtificialIntelligence
One Health interprofessional stewardship to combat antimicrobial resistance.
— Nature Medicine (@NatureMedicine) January 27, 2023
Correspondence from Claire L. Fellman and colleagues @tuftsvethttps://t.co/qXabXLxIGK pic.twitter.com/A1WfG3Bamf
“"This tool could be used to direct and track interventions to improve [antimicrobial resistance] awareness and to ascertain the success of these interventions, enabling cost-effectiveness evaluations” https://t.co/iVIHVM8vhv
— Amesh Adalja (@AmeshAA) January 27, 2023
Medical #mycology still a mystery? 🍄
— BSAC (@BSACandJAC) January 27, 2023
In our 3-week course you will learn through real-world cases how antifungal stewardship can be used to improve prescribing practices and patient care.
Sign up today! 👇 https://t.co/4L9RGIu19I pic.twitter.com/K4uW2Dj449
Japan formally decided Friday to downgrade the legal status of the novel coronavirus on May 8 to the same category as common infectious diseases, such as seasonal influenza. https://t.co/PMvGugjqBQ
— ABS-CBN News Channel (@ANCALERTS) January 27, 2023
Rate of Americans reporting long-COVID symptoms declining
— CIDRAP (@CIDRAP) January 27, 2023
Data show the share of Americans reporting long COVID has dropped over the past 6 months, while another study suggests vaccination may contribute to lower levels of #LongCOVIDhttps://t.co/VDedBTE8BC#COVID19 pic.twitter.com/gHoYAzqT6H
The K. pneumonieae (Kp) ter operon confers tellurite oxide resistance. What is its role in the context of infection? In #IAIJournal, researchers show that the operon is a stress tolerance factor that enhances Kp fitness in the gut and bladder. https://t.co/en4YYQ5zRm pic.twitter.com/EvHhgAq9Fc
— ASM (@ASMicrobiology) January 27, 2023
📢New Podcast: Prof Alasdair MacGowan joins @Charlotte_eCM, Senior Editor at eClinicalMedicine, to discuss treatment options for skin infections caused by MRSA, antimicrobial stewardship, and more!https://t.co/NIY7elZQal
— eClinicalMedicine – The Lancet Discovery Science (@eClinicalMed) January 27, 2023
Read the full paper here:https://t.co/aV6p4muz3N pic.twitter.com/fCgob0X0HH
Japan plans to reclassify the novel coronavirus to the same category as common infectious diseases such as seasonal influenz, government sources said. https://t.co/fxYGM99VqQ
— ABS-CBN News Channel (@ANCALERTS) January 27, 2023
Finding new antibiotics is only a single part of the solution to #AMR—preserving the activity of existing drugs using antibiotic adjuvants is another. Learn how these compounds maintain antibiotic efficacy to ensure treatable infections stay treatable. https://t.co/UYMaNp9ojC
— ASM (@ASMicrobiology) January 27, 2023
🆕️⚡️Retrospective analysis of case-based surveillance data from 20,000 hospitalised pts w influenza 11 EU countries ,83% from 🇪🇸
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
2010/2020
28% of patients were admitted to ICU & 14% died
78% of patients given NAI (Oseltamivir)
58% received it w/in 4dhttps://t.co/KQgBwb4TZS pic.twitter.com/yDhP0ctbmY
Unreported SARS-CoV-2 Home Testing and Test Positivity | Infectious Diseases | JAMA Network Open | JAMA Network https://t.co/fdZ9Y4IrUZ
— Dr. Saskia Popescu (@SaskiaPopescu) January 27, 2023
NIH: National Institute of Allergy & Infectious Diseases, under director Anthony Faucci, criticized by federal watchdog for lack of grant funding oversight- regarding bat coronavirus research in Wuhan. https://t.co/bOALsLeynx
— Jeremy Lee Quinn (@jeremyreporter) January 27, 2023
Researchers found that #SARSCoV2 #coronavirus infection reduces the diversity of the gut #microbiome & changes the gut lining to make blood infections more likelyhttps://t.co/gfJQmOPRzP #COVID19
— MicrobesInfect (@MicrobesInfect) January 27, 2023
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark - The Lancet Infectious Diseases https://t.co/KASE5S8WrO
— Eng Eong Ooi (@EngEongOoi) January 27, 2023
If you missed our popular December antimicrobial stewardship webinar with Dr Sharon Gardiner and Dr Matire Harwood, you can watch the recording here instead: https://t.co/WpDvDqq2Ah
— Ako Hiringa (@AkoHiringa) January 27, 2023
An expert panel of #Japan health ministry agrees to downgrade the novel #coronavirus to the same category as common infectious diseases such as seasonal influenza.https://t.co/aQnJDWkQC8#KyodoNewsPlus
— Kyodo News | Japan (@kyodo_english) January 27, 2023
HCAI and AMR point prevalence from Ukraine (2019-'21): blog based on new @jhieditor article https://t.co/mhoDDClta5 Prevalence of HCAI at 16% higher than European average of around 6-7%, with common multidrug-resistance, and a high proportion of patients on antibiotics (75%!).
— Jon Otter (@jonotter) January 27, 2023
The National Institutes of Health’s inspector general issued a "damning" report of the team led by Dr. Anthony Fauci, which funded research into coronaviruses in Wuhan, China.
— Arthur Terry (@ArthurTerry2020) January 27, 2023
National Institute of Allergy and Infectious Diseases made egregious errors. https://t.co/wc6VAs7vXy
Sonam Vijay et al. establish a framework for implementing #antimicrobial stewardship in tertiary care #hospitals in #India, and identify challenges and enablers for implementation
— The Bulletin of the World Health Organization (@WHOBulletin) January 27, 2023
🏥https://t.co/7ZUkZMbbT0 pic.twitter.com/IBLrGbrPJj
@drapurbasastry: Congratulation Sir for new title released "Essentials Of Antimicrobial Stewardship 1st Edition" by Jaypee Publication. Click here to buy https://t.co/hfV6z4knSQ pic.twitter.com/aLLgqSn5Nw
— Vipin Kumar Tanwar (@VipinKumTanwar) January 27, 2023
Opinion | Antibiotics research deserves congressional support - The Washington Post @gardp_amr https://t.co/dvPVeF7lHZ
— Laura Piddock 💙 (@LauraPiddock) January 27, 2023
Sometimes a devastating experience can change the trajectory of our career 😥
— Dena van den Bergh (@inspired2leadQH) January 27, 2023
This week I spoke with my friend and collaborator Dr Esmita Charani, a global leader in Antimicrobial Stewardship working across the UK, South Africa, India, Norway and many o…https://t.co/VJJYALiZoI
A 🆕️⚡️Systematic Review
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles #IDTwitter https://t.co/aUB3CxExN1
From 2 SARS-CoV-2 household transmission studies 61% (43/70) of 1ry cases had culturable-virus detected ≥6d post-onset
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
Risk of secondary infection among household contacts tended to be greater when primary cases had culturable-virus detected after onsethttps://t.co/NnvSqoHFgL
CCWT's efforts on monitoring #wastewater across Nassau and Suffolk County highlighted in @Newsday article "New York State plans to expand wastewater surveillance to combat infectious diseases" with quotes from Center Director, Dr. Chris Gobler https://t.co/bmWWVa2td1 #COVID19
— New York State Center for Clean Water Technology (@nysccwt) January 27, 2023
Check out our @HealthEuropa article about point-of-care testing in A&E and the learnings about POCT for Infectious Diseases from the first four waves of COVID. #COVID19 #Sepsis #EmergencyMedicine #PointofCareDiagnostics https://t.co/ZBN1HwOdNK
— Inflammatix (@Inflammatix_Inc) January 27, 2023
#COVID19 bivalent booster appears to offer added benefits against Omicron
— CIDRAP (@CIDRAP) January 27, 2023
The bivalent booster offered additional benefits against symptomatic infection and severe illness, 3 new studies showhttps://t.co/n1tmmvtBLi pic.twitter.com/MyFeZtJrmi
⛔️Preprint ⛔️
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
🆕️⚡️⚡️data suggest a signature of molnupiravir mutagenesis can be seen in global sequencing databases, in some cases with onwards transmission #IDTwitter https://t.co/zIP0mVza0k pic.twitter.com/30Awuqo3vk
#Vacancy: Research Assistant/Associate, to study the impact of #climatechange on #infectiousdiseases
— Grantham Imperial (@Grantham_IC) January 27, 2023
Post will be split between @Grantham_IC & @MRC_Outbreak
Deadline: 15 February
▶️ https://t.co/zUhYlEEHRf
COVID vaccine-boosted nursing home residents at 30% to 50% lower risk of infection
— CIDRAP (@CIDRAP) January 27, 2023
Residents not up to date on recommended #COVID19 vaccines were at a 30% to 50% higher risk for infection, according to new CDC datahttps://t.co/d4EX0hSNYl
Japan plans to reclassify the novel coronavirus to the same category as common infectious diseases such as seasonal influenza effective May 8, government sources said Thursday. #COVID19 https://t.co/ZdKUrqpRPo
— ABS-CBN News (@ABSCBNNews) January 27, 2023
Montana physicians and other health professionals will be able to take necessary steps to stop vaccine-preventable infectious diseases from spreading in their offices, thanks to a federal court ruling. https://t.co/MbahSKxzyp
— AMA (@AmerMedicalAssn) January 27, 2023
#AvianFlu strikes more US turkey farms
— CIDRAP (@CIDRAP) January 27, 2023
Commercial turkey farms in Iowa and Virginia were hit, affecting almost 40,000 birdshttps://t.co/0nlBg8qj2W
Virologists Call for Rational Discourse on Gain of Function Research - Read the new commentary published in @mbiojournal @mSphereJ and @JVirology https://t.co/N51Y6hl3CY
— ASM Newsroom (@ASMnewsroom) January 27, 2023
Alarmingly, antimicrobial-resistant germs can share their resistance mechanisms with other germs that have not been exposed to antibiotics or antifungals.
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 27, 2023
CDC #IDTwitter https://t.co/G05Efk05ud
An animal model study by investigators at Johns Hopkins Children’s Center demonstrates that an FDA-approved drug regimen for multidrug-resistant (MDR) #tuberculosis (TB) may not work against TB meningitis. Learn more: https://t.co/cBrM11ylZC pic.twitter.com/RgDsyJKnh1
— Inside Precision Medicine (@Inside_PM) January 27, 2023
How did we get to where we are now in the fight against #antibioticresistance? McMasters University’s @gerryiidr explains: https://t.co/9MY9EH8eot
— Save Antibiotics (@saveantibiotics) January 27, 2023
primary #pharmacology of #ceftazidime /#avibactam : resistance in vitro | Journal of Antimicrobial Chemotherapy | Oxford Academic. #AMR
— Mike Hornsey (@Mikerobiologist) January 27, 2023
Weekend reading 📖 https://t.co/xhFXNuoYsP
Flu continues hasty retreat in US; #COVID, RSV markers fall
— CIDRAP (@CIDRAP) January 27, 2023
In another COVID development, the FDA pulled its EUA for Evusheld, the last available monoclonal antibody treatment, due to weak activity against the newer circulating subvariants.https://t.co/dTEEPnMHvL pic.twitter.com/UjqiY7JeHy
Impaired immune response & barrier function in GSPD-1-deficient C. elegans infected with #Klebsiella pneumoniae.
— MicrobesInfect (@MicrobesInfect) January 27, 2023
The innate immune response was the most important pathway affected by GSPD-1, which maintained tight junction & intestinal barrier integrityhttps://t.co/VRDWIp5IQK pic.twitter.com/JrboTJYa3G
Quadripartite launches technical group on surveillance of antimicrobial use, resistance
— CIDRAP (@CIDRAP) January 27, 2023
The WHO & partner organizations say the group will help guide countries in their efforts to monitor antimicrobial use and resistancehttps://t.co/g37AACf9kA#AMR
Dr Gilman Siu Kit-hang is a recipient of the Outstanding #PolyU Young Alumni Award 2022. His rapid sequencing technique has increased the efficiency of the diagnosis of infectious diseases. Watch the video to know more about his academic achievements! https://t.co/FXd2MU3fKp
— The Hong Kong Polytechnic University (PolyU) (@HongKongPolyU) January 27, 2023
In this week’s #COVID19 update, I discuss the #XBB15 variant, #vaccination news, and the possibility of an #endemic virus.
— Chris Ohl, MD (@ChrisOhlMD) January 27, 2023
Watch ⤵️https://t.co/JNNwqSu8Nu
The reason for the uptick in invasive strep cases is currently unknown, but could be connected to post-#COVID19 activities
— Haydon howletth (@Haydon18167592) January 27, 2023
join #emerging #infectiousdiseases to learn about the recent researches
submit abstract at: https://t.co/tfkgqovO4h
(+44) 7915638336#Health #epidemiology pic.twitter.com/rqb0eAsYhW
Excited to have my PGY1 residency project published. Great work and many thanks to the excellent multi-disciplinary team in helping make this pilot project a success! 🙏@Docalergias @AlejandroHalloC @SretroPMD #TwitteRx #IDTwitter #AntimicrobialStewardship https://t.co/Yn5P3kvtzl
— Devon Stonerock, PharmD (@DevonStoneRx) January 27, 2023
If you've had your first dose make sure to get your second. Get ready to celebrate this pride season and book your shot now.
— Victorian Pride Lobby (@VicPrideLobby) January 27, 2023
Find metropolitan Melbourne vaccination sites https://t.co/7bQLcN3Imj
Find regional Victoria vaccination sites https://t.co/9XLSrCgtoJ
#DYK? #Flu viruses spread mainly by droplets made when people with flu cough, sneeze, or talk. Staying home and keeping your distance from others if you have flu is a good way to protect others. https://t.co/4Uggd6S0IA
— Battle Superbugs ☮️ (@battlesuperbugs) January 27, 2023
The cull continues:
— Sarah (@scooternan) January 27, 2023
"Devon care homes say they are being asked to accept patients with Covid-19, flu and other infectious diseases to ease the pressure on local hospitals"https://t.co/oGWhHSKz21
Today at 🕐13:00 CET, join the #VirtualPub with Jacomine Krijnse Locker, @PEI_Germany, on “Electron Microscopic imaging: Past and future perspectives.”
— Euro-BioImaging ERIC (@EuroBioImaging) January 27, 2023
It's going to be a great talk!#infectiousdiseases #ElectronMicroscopy
Register here⤵️https://t.co/ZKBjqv1GkQ pic.twitter.com/7qY0SVNyBC
https://t.co/ONsftCOv18
— Adam Kleczkowski (@aklecz) January 27, 2023
Seasonal infectious diseases like Norovirus are back to a "normal" pattern, but the numbers are higher - possibly because #covid affects our immunity. pic.twitter.com/gOMNKHpE9c
Created by Cameron Forbes. Last updated January 31, 2023 at 05:16 EST.